Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of neurocognitive decline in cancer patients, except brain cancer, under long-term treatment with bevacizumab.
Panciroli C, Lucente G, Vidal L, Carcereny E, Quiroga V, Pardo JC, Romeo M, Estival A, Manzano JL, Pardo B, Velarde JM, Esteve AM, Lopez D, Mañes A, Tuset V, Villà S, Quintero CB. Panciroli C, et al. Among authors: manes a. Clin Transl Oncol. 2020 Mar;22(3):411-419. doi: 10.1007/s12094-019-02143-6. Epub 2019 May 29. Clin Transl Oncol. 2020. PMID: 31144211
Postoperative radiotherapy provides better local control and long-term outcome in selective cases of cutaneous squamous cell carcinoma with perineural invasion.
Cañueto J, Jaka A, Corchete LA, González-Pérez AM, García-Castro R, Fuente MJ, Membrive I, March Á, Mañes A, Posada R, Pujol RM, Román-Curto C, Toll A. Cañueto J, et al. Among authors: manes a. J Eur Acad Dermatol Venereol. 2020 May;34(5):1080-1091. doi: 10.1111/jdv.16001. Epub 2019 Nov 12. J Eur Acad Dermatol Venereol. 2020. PMID: 31587379
Is oligoprogression a potentially curable disease in epidermal growth factor receptor mutant lung adenocarcinoma?
Chekhun S, Lopez-Paradís A, Urbizu A, Morán T, Mañes A, Cucurull M, Martínez-Barenys C, Teruel I, Moragas G, Carcereny E, Muñoz Mármol AM, Saigí M. Chekhun S, et al. Among authors: manes a. Explor Target Antitumor Ther. 2023;4(6):1182-1187. doi: 10.37349/etat.2023.00191. Epub 2023 Dec 13. Explor Target Antitumor Ther. 2023. PMID: 38213544 Free PMC article.
105 results